BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2016
View Archived Issues
European Commission awards orphan drug designation to SENS-401
Read More
Primary analysis results for phase III trial of tau-aggregation inhibitor therapy
Read More
Aptinyx presents in vitro and in vivo data for its NMDA receptor modulator JY-515317
Read More
Atom Bioscience and Pharmaceutical patents anticancer agents
Read More
Tarveda initiates phase I/IIa study of PEN-221 in SSTR2-expressing advanced cancers
Read More
FDA clears TopiVert's IND for phase I/IIa study of TOP-1630 in dry eye syndrome
Read More
GSK announces MAA submission to the EMA for Shingrix
Read More
Zebrafish model of fatty liver reveals role of 12-lipoxygenase
Read More
Chugai and Berlin-Chemie Menarini sign global license agreement for PA-799
Read More
Intellipharmaceutics submits NDA in U.S. for Rexista
Read More
Johnson & Johnson in preliminary discussions with Actelion
Read More
Ambroxol could be repurposed to treat fibromyalgia
Read More
AbbVie initiates phase I trial of ABBV-428 in advanced solid tumors
Read More
Phase III rheumatoid arthritis study finds equivalence between rituximab and biosimilar CT-P10
Read More
New TRPC4/5 inhibitor shows promise for anxiety and depression
Read More
HVTN initiates phase IIb/III trial of investigational HIV vaccine regimen in South Africa
Read More
Santen announces topline results from SAKURA phase III program of Opsiria
Read More
Data validate SIME Dx's lung maturity test for identifying infants at risk of RDS
Read More
Araim Pharmaceuticals' ARA-290 granted orphan drug designation in E.U.
Read More
Enrollment completed in phase IIa study of Serodus' SER-150
Read More
PharmaMar begins phase I study of lurbinectedin in Japan
Read More
Results mixed with everolimus and low-dose CIs in pediatric liver transplant recipients
Read More
